510(k) Report

510(k) · Cleared

Cleared

R&D Retic-PG Hematology Control

K961673510(k) TraditionalCleared Jul 15, 199675-day reviewClass II21 CFR 864.8625

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

R&D Systems, Inc. · JPK Mixture, Hematology Quality Control

Cleared on Jul 15, 1996 as substantially equivalent to K943336 (R&D Systems, Inc., 1994) after a 75-day review. Its family tree reaches back 1 generation to 1994.

Decided
Jul 15, 1996
Review
75 days
Class
Class II
Product code
JPK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K943336 (1994). No later device cites it as a predicate yet.

  1. Root · 1 generation backK943336 Retic Control-H Hematology Control/MultipleR&D Systems, Inc. · 1994
  2. This deviceK961673 R&D Retic-PG Hematology ControlR&D Systems, Inc. · 1996
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K943336Retic Control-H Hematology Control/MultipleR&D Systems, Inc.1994—
0 (this device)K961673R&D Retic-PG Hematology ControlR&D Systems, Inc.1996—
FIG. 1 — Lineage of K961673, 1994–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K943336Retic Control-H Hematology Control/Multiple
Summary page 1
…e. R&D Retic-I™ is a trademark of R&D Systems, Inc., 614 McKinley Place N. E., Minneapolis, MN 55413. The FDA document number for the predicate device, R&D Retic-I™, is K943336. Device description: R&D Retic-PG is an in vitro diagnostic reagent composed of human erythrocytes and a reticulocyte surrogate…
R&D Systems, Inc.1994—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JPK devices

JPK Mixture, Hematology Quality Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JPK

4in 2016

2007: 52009: 52010: 42011: 12012: 22013: 12014: 22016: 4
2007high 5 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPK

296in 2016

2007: 44 days median2009: 187 days median2010: 267 days median2016: 296 days median
2007high 296 (2016) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPK

1in 2022

2007: 12010: 22011: 32012: 12020: 12021: 22022: 1
2007high 3 (2011) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPK

2in 2023

2007: 142008: 12010: 52011: 562012: 22014: 12019: 12020: 12021: 12023: 2
2007high 56 (2011) · low 0 (2009)2025

MAUDE reports naming product code JPK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007544114
20080—01
2009518700
2010426725
20111—356
20122—12
20131—00
20142—01
20150—00
2016429600
20170—00
20180—00
20190—01
20200—11
20210—21
20220—10
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

R&D Retic-PG™ is a tri-level, assayed hematology control designed to document and monitor reticulocyte values obtained from the CELL-DYN® 3500 System.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K961673: R&D Retic-PG Hematology Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K961673

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026